Comparison of suppository Morphine with suppository Diclofenac on postoperative pain laparoscopic cholecystectomy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013022012540N1

Enrollment

Registered

2013-11-27

Start date

2014-01-05

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain. Acute Pain

Interventions

Intervention 1: Diclofenac: - Dose: 100 mg - Number of using: Once Factory name: Behvazan Manufacturing Country's Name: Iran Location prescribed: Suppository Administration time: after end of surger

Treatment - Drugs

Diclofenac: - Dose: 100 mg - Number of using: Once Factory name: Behvazan Manufacturing Country's Name: Iran Location prescribed: Suppository Administration time: after end of surgery

Morphine: - Dose: 10 mg - Number of using: Once Factory name: Abureihan Manufacturing Country's Name: Iran Location prescribed: Suppository Administration time: after end of surgery

Eligibility

Sex/Gender

All

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Criteria for inclusion of study: ASA class I & II; years old 50-20. Criteria for exclusion of study: History of hypnotics or narcotics throughout 24 hours before the surgery; Contraindication of morphine or diclofenac; Renal or hepatic failure; Peptic ulcer disease or rheumatoid arthritis.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: 1, 2, 3, 4, 6 and 8 hours after surgery. Method of measurement: Visual Analogue Scale.	—

Secondary

Measure	Time frame
Opioid Consumption. Timepoint: 1, 2, 3, 4, 6 and 8 hours after surgery. Method of measurement: Milligrams.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFereshte Amiri

Ahvaz Jundishapur University of Medical Sciences

fatahi.m@ajums.ac.ir; mostafafatahi777@gmail.com+98 61 1432 5879

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026